Therefore, I think it is reasonable to question whether or not IMGN has unfettered access to the improved linker tech devised by DNA.
My understanding it was a joint development and they do.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr